STEXUVEQ Trademark

Trademark Overview


On Friday, April 28, 2023, a trademark application was filed for STEXUVEQ with the United States Patent and Trademark Office. The USPTO has given the STEXUVEQ trademark a serial number of 79371341. The federal status of this trademark filing is REGISTERED as of Tuesday, January 30, 2024. This trademark is owned by NOVARTIS AG. The STEXUVEQ trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
stexuveq

General Information


Serial Number79371341
Word MarkSTEXUVEQ
Filing DateFriday, April 28, 2023
Status700 - REGISTERED
Status DateTuesday, January 30, 2024
Registration Number7292509
Registration DateTuesday, January 30, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 14, 2023

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events


Event DateEvent Description
Monday, March 25, 2024NOTIFICATION PROCESSED BY IB
Friday, March 1, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 1, 2024FINAL DISPOSITION PROCESSED
Thursday, February 29, 2024GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, January 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 30, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2023PUBLISHED FOR OPPOSITION
Monday, November 13, 2023NOTIFICATION PROCESSED BY IB
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 25, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 10, 2023ASSIGNED TO EXAMINER
Thursday, June 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 29, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, June 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 27, 2023APPLICATION FILING RECEIPT MAILED
Thursday, June 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 21, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 8, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB